Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Location status: Recruiting
NCT Number: NCT07455513
This clinical trial evaluates the feasibility of a novel tobacco cessation resource called a Buckeye Quit Stick among smokers with a diagnosed or suspected thoracic cancer. Tobacco use is the single most preventable cause of disease, disability, and death in the United States. While the benefits of quitting smoking are numerous, rates of persistent smoking after cancer diagnosis remain high. Research has found that patients who quit smoking but subsequently relapse frequently report the hand/oral habit as a barrier to sustained smoking cessation. The Buckeye Quit Stick is an innovative cessation aid designed to directly address patients' hand/oral habit by substituting the cessation aid for cigarettes without integrating pharmacologic intervention, which is typically managed by their medical provider and may require direct supervision due to the patient's health status. The Buckeye Quit Stick is designed to satisfy the repeated hand/oral pattern or ritual, thereby avoiding the physical loss of holding a cigarette in the hand or mouth and the action of smoking. It may also help occupy fidgeting hands and potentially reduce stress and cravings. This novel cessation resource may address key factors that influence smoking abstinence and improve patients' health outcomes.
Interested in participating?
Request Info21 year and older
All sexes
Interventional
Not applicable
Columbus, Ohio, 43210, United States
Location status: Recruiting
PRIMARY OBJECTIVE:
I. To evaluate the feasibility and acceptability of the Buckeye Quit Stick among 30 patients seen in the Ohio State University (OSU) thoracic clinic(s) and to characterize frequency of use among the accrued sample.
EXPLORATORY OBJECTIVES:
I. Characterizing the population. II. Determining communication preferences, acceptance of the Buckeye Quit Stick, abstinence estimates.
III. Assessing the quality of subjective measures (e.g., anxiety, quality of life, etc.).
IV. Gathering qualitative data to elicit participant feedback regarding the device, The James Comprehensive Cancer Center (CCC) smoking cessation clinic, and overall study design.
OUTLINE:
Patients receive a Buckeye Quit Stick and a smoking cessation informational packet on study. Patients also receive a referral to the James CCC smoking cessation clinic on study.
After completion of study intervention, patients are followed up at 2 weeks, 3 and 6 months, and then up to 24 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ancillary studies
Receive smoking cessation information
Ancillary studies
Receive referral
Other names: Referred
Receive Buckeye Quit Stick
Other names: Smoking and Tobacco Use Cessation Interventions
Ancillary studies
Time frame: Up to 1 year
To evaluate feasibility, recruitment rates will be defined as the proportion of screened adults accrued relative to those approached in the Ohio State University Comprehensive Cancer Center thoracic oncology clinic.
Time frame: at baseline, 2 weeks, 3 months and 6 months
Adherence will be assessed by evaluating the proportion of retained participants at each timepoint who complete required study procedures and assessments at each timepoint
Time frame: At 2 weeks, 3 months, and 6 months
Retention rates will be defined as the percentage of participants not lost to follow-up at 2-weeks, 3-months and 6-months post-enrollment. Descriptive statistics will be performed.
Contact information is provided by the study sponsor or research team.
Ohio State University Comprehensive Cancer Center
Other
A Pilot/Feasibility Study of the Buckeye Quit Stick: A Novel Resource for Successful Tobacco Cessation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05121051
Cigarette Smoking-Related Carcinoma
Tucson, Arizona, United States
View Trial DetailsNCT05008848
Cigarette Smoking-Related Carcinoma
Kingman, Arizona, United States
View Trial DetailsNCT06763536
Cigarette Smoking-Related Carcinoma
Columbus, Ohio, United States
View Trial DetailsNCT06213532
Behavior, Cigarette Smoking-Related Carcinoma
San Francisco, California, United States
View Trial Details